Ads
related to: microbiome therapeutics companies reviews
Search results
Results from the WOW.Com Content Network
In March 2010, [4] and again in March 2011, Joule Unlimited was named by Technology Review as one of the 50 Most Innovative Companies. [5] In 2012, Berry founded Seres Therapeutics, which pioneered microbiome therapeutics. [6] The company raised over $130M as a private company, including a $65M investment from Nestle Health Sciences. [7]
OpenBiome is a nonprofit health research organization based in Massachusetts accelerating research on the human microbiome. They partner with leading researchers, clinicians and innovators to advance and ensure access to novel and affordable microbiome therapeutics.
AOBiome was founded in 2013 with a mission to study the effects of AOB on the skin microbiome and overall skin health. They have since performed in-vitro studies, in-vivo studies, and two human studies in acne vulgaris, the results of which have led the company to now additionally explore systemic therapies for conditions such as hypertension.
As of 2019, twelve of top 20 biopharmaceutical companies in the world has U.S. headquarters in the state. [ 9 ] [ 10 ] Below is a list of notable New York metropolitan area biotechnology and pharmaceutical corporations , including companies with either global or U.S. headquarters in the metropolitan region encompassing and surrounding New York ...
The FDA granted the application for fecal microbiota spores, live-brpk priority review, breakthrough therapy, and orphan drug designations. [2] The FDA granted approval of Vowst to Seres Therapeutics Inc. [ 2 ]
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
He served as chief technology officer at Seres when the company developed SER-109, one of the first microbiome therapeutics. [14] In 2018, von Maltzahn cofounded two biotechnology startups, Generate Biomedicines [15] and Tessera Therapeutics. [16] Two years later he became a general partner at Flagship. [17]
Second Genome is a venture capital funded, life sciences research company based in South San Francisco. [1] The company's focus is on the development and exploitation of a research platform which facilitates the identification and elucidation of relationships between human physiology and the human microbiota, [1] [2] and it has a long term goal of becoming a drug development company. [3]
Ads
related to: microbiome therapeutics companies reviews